![Mark Frans van Coeverden de Groot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Frans van Coeverden de Groot
Directeur Général chez Pattern Pharma, Inc.
Provenance du réseau au premier degré de Mark Frans van Coeverden de Groot
Entité | Type d'entité | Industrie | |
---|---|---|---|
Pattern Pharma, Inc.
![]() Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark Frans van Coeverden de Groot via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of British Columbia | College/University | Doctorate Degree Graduate Degree | |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Pharmaceuticals: Other | Director/Board Member | |
MEDITE CANCER DIAGNOSTICS INC | Medical Specialties | Director/Board Member | |
OHK Medical Devices, Inc.
![]() OHK Medical Devices, Inc. Medical SpecialtiesHealth Technology OHK Medical Devices, Inc. develops and manufactures self-contained, sterile, exsanguinating tourniquet products. Its products include hand and wrist, foot and ankle, upper extremity, lower extremity and pediatrics. The company was founded by Noam Gavriely in 1999 and is headquartered in Grandville, MI. | Medical Specialties | Director/Board Member | |
NEUROTROPE, INC. | Pharmaceuticals: Major | Chairman | |
Dalyda Finance LLC | Corporate Officer/Principal | ||
Higuchi Bioscience Center | Director/Board Member | ||
Bryologyx, Inc.
![]() Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Pharmaceuticals: Major | Founder | |
Hadean Ventures AS
![]() Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor | |
International Opera Alliance
![]() International Opera Alliance Miscellaneous Commercial ServicesCommercial Services International Opera Alliance is an entertainment company focused on musical and arts activities. The company is headquartered in Fairfax, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Oncolyze, Inc.
![]() Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Biotechnology | Founder | |
Simon Fraser University | College/University | Doctorate Degree | |
University of East Anglia | College/University | Undergraduate Degree | |
Viventia Biotech, Inc.
![]() Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Executive Officer | |
MEI PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Players Club | Corporate Officer/Principal | ||
Combimatrix Molecular Diagnostics, Inc. | Director/Board Member | ||
AiVita Biomedical, Inc.
![]() AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Founder | |
Alison Raffaele Cosmetics, Inc.
![]() Alison Raffaele Cosmetics, Inc. Specialty StoresRetail Trade Alison Raffaele Cosmetics, Inc. manufactures cosmetics and facial makeup products. Its products include powder, lipstick, lip gloss and blush, tools, and brushes. The firm was founded by Alison Raffaele Tatem in 2000 and is headquartered in Cliffside Park, NJ. | Specialty Stores | Director/Board Member | |
SFC CO LTD | Containers/Packaging | Director/Board Member | |
University of Cambridge | College/University | Undergraduate Degree | |
Immunis, Inc.
![]() Immunis, Inc. Miscellaneous Commercial ServicesCommercial Services Immunis, Inc. is a biotechnology company that focuses on developing innovative STEM treatments for immune decline related to age and disease, such as osteoporosis, osteoarthritis, and sarcopenia. The company is based in Irvine, CA. The company is currently conducting clinical trials for participants with leg muscle atrophy or weakness due to osteoarthritis/sarcopenia. Immunis aims to change the course of immune-related diseases and aging. | Miscellaneous Commercial Services | Chairman | |
I-Flow Corp.
![]() I-Flow Corp. Medical SpecialtiesHealth Technology I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA. | Medical Specialties | Director/Board Member | |
ORYX TECHNOLOGY CORP. | Electrical Products | Director/Board Member | |
DUSA Pharmaceuticals, Inc.
![]() DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Pharmaceuticals: Major | Director/Board Member | |
MedVest, Inc. | Founder | ||
COMBIMATRIX CORP | Biotechnology | Director/Board Member | |
Medisync Midwest LLC
![]() Medisync Midwest LLC Miscellaneous Commercial ServicesCommercial Services Medisync Midwest LLC provides consultation services. It offers practice management partnership, clinical research, volume to value planning, diagnostic assessments, and HCC program. The company is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Director/Board Member | |
International University of Health Sciences | College/University | Corporate Officer/Principal | |
University of Birmingham | College/University | Doctorate Degree | |
UniMedica, Inc. | Chairman | ||
Northlea Partners LLLP | Corporate Officer/Principal | ||
CONTRAFECT CORPORATION | Biotechnology | Founder | |
Etubics Corp.
![]() Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Baystar Biosciences | Director/Board Member | ||
Medezrin Ltd. | Director/Board Member | ||
Lumira Capital Investment Management, Inc.
![]() Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Chief Investment Officer |
Statistiques
Internationale
Etats-Unis | 34 |
Canada | 6 |
Royaume-Uni | 6 |
Norvège | 2 |
Corée du Sud | 2 |
Sectorielle
Health Technology | 20 |
Consumer Services | 7 |
Finance | 6 |
Commercial Services | 5 |
Retail Trade | 2 |
Opérationnelle
Director/Board Member | 33 |
Independent Dir/Board Member | 6 |
Corporate Officer/Principal | 6 |
Chairman | 5 |
Founder | 5 |
Relations les plus connectées
Insiders | |
---|---|
John H. Abeles | 33 |
Nick Glover | 10 |
Hans S. Keirstead | 7 |
Yann Rioux | 1 |
Elizabeth Acosta | 1 |
Andrew Williams | 1 |
- Bourse
- Insiders
- Mark Frans van Coeverden de Groot
- Connexions Sociétés